Relative impact of HLA phenotype and CD4-CD8 ratios on the clinical expression of hemochromatosis

被引:65
作者
Porto, G
Vicente, C
Teixeira, MA
Martins, O
Cabeda, JM
Lacerda, R
Goncalves, C
Fraga, J
Macedo, G
Silva, BM
Alves, H
Justica, B
deSousa, M
机构
[1] INST CIENCIAS BIOMED ABEL SALAZAR,DEPT BIOSTAT,P-4050 OPORTO,PORTUGAL
[2] SANTO ANTONIO GEN HOSP,DEPT HEMATOL,OPORTO,PORTUGAL
[3] SANTO ANTONIO GEN HOSP,DEPT GASTROENTEROL,OPORTO,PORTUGAL
[4] REG HLTH ADM,DEPT INTERNAL MED,VALE DO SOUSA,PORTUGAL
[5] S JOAO GEN HOSP,DEPT GASTROENTEROL,OPORTO,PORTUGAL
[6] N HISTOCOMPATIBIL CTR,OPORTO,PORTUGAL
关键词
D O I
10.1002/hep.510250223
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hemochromatosis is a hereditary iron-overload disease linked to HLA. The clinical expression of hemochromatosis is influenced by sex and age, However, other factors must account for the notorious heterogeneity of expression of the disease independent of sex, age, and HLA phenotype. The present study attempts to clarify some of these additional factors based on exhaustive statistical analysis of data collected from 43 selected patients with hemochromatosis, The statistical analysis focused on three groups of variables: the first group included variables reflecting the clinical expression of the disease; the second group represented the biochemical and hematological values at the time of diagnosis; and the third group consisted of the independent variables sex, age, HLA phenotype, and T-cell subset profile, i.e., the percentages and total numbers of CD4+ and CD8+ cells and the CD4-CD8 ratios. The results show that the relative expansion of the two main T-cell subsets, in the context of the HLA phenotype, correlates significantly with the clinical expression of hemochromatosis and the severity of iron overload. The present findings substantiate further the postulate that T cells have a role in the regulation of iron metabolism.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 35 条
[1]  
ADAMS PC, 1991, AM J MED, V90, P445
[2]   GENETIC-CONTROL OF THE CD4/CD8 T-CELL RATIO IN HUMANS [J].
AMADORI, A ;
ZAMARCHI, R ;
DESILVESTRO, G ;
FORZA, G ;
CAVATTON, G ;
DANIELI, GA ;
CLEMENTI, M ;
CHIECOBIANCHI, L .
NATURE MEDICINE, 1995, 1 (12) :1279-1283
[3]   HEREDITARY HEMOCHROMATOSIS - PHENOTYPIC-EXPRESSION OF THE DISEASE [J].
CARTWRIGHT, GE ;
EDWARDS, CQ ;
KRAVITZ, K ;
SKOLNICK, M ;
AMOS, DB ;
JOHNSON, A ;
BUSKJAER, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (04) :175-179
[4]  
CHAKRAVARTI A, 1995, NATURE MED, V12, P1240
[5]   HLA CLASS-I AND H-FERRITIN GENE POLYMORPHISMS IN NORMAL SUBJECTS AND PATIENTS WITH HEMOCHROMATOSIS [J].
CRAGG, SJ ;
DARKE, C ;
WORWOOD, M .
HUMAN GENETICS, 1988, 80 (01) :63-68
[6]   IRON OVERLOAD IN BETA(2)-MICROGLOBULIN-DEFICIENT MICE [J].
DESOUSA, M ;
REIMAO, R ;
LACERDA, R ;
HUGO, P ;
KAUFMANN, SHE ;
PORTO, G .
IMMUNOLOGY LETTERS, 1994, 39 (02) :105-111
[7]  
DESOUSA M, 1982, MEM I OSWALDO CRU S5, V87, P23
[8]  
DESOUSA M, 1984, VITAMINS NUTRITION C, P231
[9]  
HANN HWL, 1990, CANCER, V66, P313, DOI 10.1002/1097-0142(19900715)66:2<313::AID-CNCR2820660219>3.0.CO
[10]  
2-J